Welcome to our dedicated page for Oppenheimer Hld news (Ticker: OPY), a resource for investors and traders seeking the latest updates and insights on Oppenheimer Hld stock.
Oppenheimer Holdings Inc. (NYSE: OPY) is a middle market investment bank and full service broker-dealer active in the investment banking and securities industry. Through its subsidiaries, including Oppenheimer & Co. Inc., the firm reports news on retail securities brokerage, institutional sales and trading, investment banking, equity and fixed income research, market-making, trust services, and investment advisory and asset management services.
The OPY news flow frequently includes quarterly earnings releases detailing segment results for Wealth Management and Capital Markets, trends in assets under management, and commentary from management on market conditions. Investors can follow updates on advisory and underwriting activity, equities and fixed income trading volumes, and changes in revenue components such as commissions, advisory fees, and bank deposit sweep income.
Company announcements also highlight capital actions and corporate events, such as the declaration of quarterly and special cash dividends on Class A non-voting and Class B voting common stock, as reported in press releases and related Form 8-K filings. In addition, Oppenheimer regularly reports on senior hires and team expansions across its platform, including appointments in Healthcare Equity Capital Markets, biotech research, public finance investment banking, cash equity sales and trading, and regional wealth management leadership.
Other OPY news items describe the evolution of the firm’s Custody and Prime Services (CAPS) platform and the expansion of its global credit and high yield and distressed businesses in the U.S., Europe, and Asia. For readers tracking OPY, this news page offers a centralized view of earnings updates, strategic hires, platform developments, and capital-related announcements drawn from company press releases and disclosures.
Oppenheimer & Co. Inc. has appointed Jean-Marie Gianni as Managing Director in its Global Consumer Investment Banking Group, based in New York. Gianni brings over 15 years of experience, particularly in the Health & Beauty and Personal Care sectors, aimed at enhancing the firm's consumer coverage, including health-focused food & beverage and cannabis segments in North America.
The appointment reflects Oppenheimer's commitment to expanding its investment banking leadership, following a record-setting investment banking revenue of $222.3 million in 2020, and a 219% increase in revenue in the first half of 2021.
Zamansky LLC is investigating Oppenheimer & Co. Inc. (OPY) on behalf of customers affected by the Horizon Private Equity III Ponzi scheme. The SEC had previously filed a complaint against the scheme, which raised $110 million from 400 investors, led by former Oppenheimer advisor John Wood. Allegations include failure to supervise and aiding in wrongful acts. Zamansky asserts that affected customers may have valid FINRA claims for their losses. The law firm invites Oppenheimer customers who invested in Horizon to discuss their legal rights.
Oppenheimer & Co. Inc. successfully concluded its 24th Annual Technology, Internet & Communications Conference from August 9-11, 2021. The virtual event connected over 700 institutional investors with more than 150 leading public and disruptive private technology companies. Oppenheimer's Head of Technology Investment Banking, Robin Graham, highlighted the essential role of technology in economic evolution post-COVID-19. Erica L. Moffett, Managing Director, emphasized the conference's focus on trends in SaaS, cloud computing, and analytics, underscoring Oppenheimer's commitment to fostering valuable investor-company dialogues.
Oppenheimer Holdings reported a strong second quarter of 2021 with net income of $31.2 million or $2.46 per share, marking a 76.5% increase from last year. Revenue reached $340.3 million, a 28.5% increase year-over-year, reflecting robust investment banking performance driven by higher equity underwriting and M&A fees. The firm announced a 25% dividend increase to $0.15 per share, and assets under management totaled $43.7 billion, a significant rise from prior periods. However, low interest rates continued to impact Wealth Management profitability.
Oppenheimer & Co. has expanded its Global Technology Investment Banking Group with the appointment of Maxwell Gover as Managing Director, effective July 6, 2021. Gover, with over 12 years of experience, will focus on strategic advisory and capital raising within the interactive media and communications sectors. This move is part of Oppenheimer's strategy to enhance its technology investment banking capabilities. The firm reported a 70% increase in full-year investment banking revenue for 2020, reaching $222 million, with Q1 2021 revenue surging 384% to $124.5 million.
On June 15, 2021, Oppenheimer announced significant expansion of its Financial Institutions investment banking group with the hiring of veteran bankers Cliff Booth and JD Nelson. Booth takes the role of Managing Director and Head of Specialty Finance Investment Banking, while Nelson will serve as Managing Director in Specialty Finance. Additionally, Mitchel Penn joins as Managing Director for Equity Research, enhancing the firm's focus on business development corporations. This strategic growth aims to support Oppenheimer's impressive investment banking performance, which saw revenues surge to $222 million in 2020, up 70% from 2019.
Oppenheimer Holdings reported a net income of $38.7 million or $3.07 per share for Q1 2021, soaring 400% compared to $7.8 million or $0.61 per share in Q1 2020. Revenue reached $373.3 million, a 59% increase from $234.8 million in the prior year. The growth was driven by strong equity underwriting, particularly in healthcare and technology sectors, and a flourishing M&A advisory business. However, increased compensation costs of $11.6 million impacted earnings. The company also announced a quarterly dividend of $0.12 per share.
On March 23, 2021, Oppenheimer announced key additions to its Healthcare Investment Banking team, enhancing its capabilities in M&A and capital raising. Jonathan Fassberg joins as Vice Chairman, with his extensive experience in biotech and life sciences. Brian Korb and Don Ritucci assume Managing Director roles, with Ritucci heading Healthcare M&A. These strategic hires aim to strengthen Oppenheimer's position in the fast-growing healthcare sector and offer comprehensive advisory services to clients.
Oppenheimer successfully concluded its 31st Annual Healthcare Conference held virtually from March 16-18, 2021. The event showcased discussions from over 240 healthcare companies, focusing on key industry trends and investment opportunities. Oppenheimer's Healthcare Investment Banking team reported a 73% increase in bookrun deal volume and a 50% rise in average deal size in the past year. The conference featured notable keynotes, including Dr. Scott Gottlieb discussing the COVID-19 'endgame,' emphasizing the industry's crucial role in economic recovery.
Oppenheimer Holdings reported a significant rise in Q4 2020, with net income of $81.9 million ($6.56 EPS), up from $25.4 million ($1.99 EPS) in Q4 2019. Q4 revenue increased by 42.9% to $422.9 million, while FY 2020 net income rose to $123.0 million ($9.73 EPS), compared to $53.0 million in FY 2019. Revenue for FY 2020 was $1.2 billion, a 16.0% increase year-over-year. Record performance was noted in both the Asset Management and Capital Markets segments, attributed to high volatility and strong equity markets.